SG11201407536UA - Topical pharmaceutical compositions comprising terbinafine and urea - Google Patents
Topical pharmaceutical compositions comprising terbinafine and ureaInfo
- Publication number
- SG11201407536UA SG11201407536UA SG11201407536UA SG11201407536UA SG11201407536UA SG 11201407536U A SG11201407536U A SG 11201407536UA SG 11201407536U A SG11201407536U A SG 11201407536UA SG 11201407536U A SG11201407536U A SG 11201407536UA SG 11201407536U A SG11201407536U A SG 11201407536UA
- Authority
- SG
- Singapore
- Prior art keywords
- reinbek
- international
- scholtzstrabe
- terbinafine
- urea
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000004202 carbamide Substances 0.000 title abstract 3
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title abstract 3
- 229960002722 terbinafine Drugs 0.000 title abstract 3
- 239000012049 topical pharmaceutical composition Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261646650P | 2012-05-14 | 2012-05-14 | |
| EP20120003791 EP2664327A1 (en) | 2012-05-14 | 2012-05-14 | Topical pharmaceutical compositions comprising terbinafide and urea |
| PCT/EP2013/059814 WO2013171159A1 (en) | 2012-05-14 | 2013-05-13 | Topical pharmaceutical compositions comprising terbinafine and urea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407536UA true SG11201407536UA (en) | 2014-12-30 |
Family
ID=46148606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407536UA SG11201407536UA (en) | 2012-05-14 | 2013-05-13 | Topical pharmaceutical compositions comprising terbinafine and urea |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20150111971A1 (es) |
| EP (2) | EP2664327A1 (es) |
| JP (1) | JP2015516455A (es) |
| KR (1) | KR20150013162A (es) |
| CN (1) | CN104302281A (es) |
| AR (1) | AR091039A1 (es) |
| AU (1) | AU2013261918A1 (es) |
| BR (1) | BR112014028280A2 (es) |
| CA (1) | CA2872210A1 (es) |
| CL (1) | CL2014003081A1 (es) |
| CO (1) | CO7131352A2 (es) |
| EA (1) | EA201492091A1 (es) |
| HK (1) | HK1202808A1 (es) |
| IL (1) | IL235241A0 (es) |
| MX (1) | MX2014013851A (es) |
| PH (1) | PH12014502512A1 (es) |
| SG (1) | SG11201407536UA (es) |
| TW (1) | TW201350107A (es) |
| WO (1) | WO2013171159A1 (es) |
| ZA (1) | ZA201407655B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201317005D0 (en) * | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| SG11201703184SA (en) | 2014-10-21 | 2017-05-30 | Hexima Ltd | A method of treatment |
| GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| US20210401768A1 (en) * | 2017-02-15 | 2021-12-30 | Botanix Pharmaceuticals Ltd. | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| EP3492068A1 (en) * | 2017-12-01 | 2019-06-05 | NCP NewCare Products GmbH | Composition for treating onychomycosis |
| WO2019214838A1 (en) * | 2018-05-09 | 2019-11-14 | Eviderm Institute Ab | Use of an alcohol-containing composition for improving the skin barrier function |
| PL245223B1 (pl) * | 2019-01-10 | 2024-06-03 | Biotts Spolka Akcyjna | Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna go zawierająca |
| JP6591100B1 (ja) * | 2019-01-25 | 2019-10-16 | ロート製薬株式会社 | 爪及び爪周り用医薬組成物 |
| WO2024038427A1 (en) * | 2022-08-17 | 2024-02-22 | Lyotropic Delivery Systems Ltd. | Topical delivery of antifungal agents for treating fungal infections |
| KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
| WO2011014850A2 (en) * | 2009-07-31 | 2011-02-03 | Nuvo Research Inc. | Topical eutectic-based formulations |
| AU2010336441B2 (en) * | 2009-12-23 | 2015-02-05 | Nuvo Research Inc. | Highly permeating terbinafine formulation for treating onychomycosis |
-
2012
- 2012-05-14 EP EP20120003791 patent/EP2664327A1/en not_active Withdrawn
-
2013
- 2013-05-13 TW TW102116868A patent/TW201350107A/zh unknown
- 2013-05-13 CN CN201380025181.7A patent/CN104302281A/zh active Pending
- 2013-05-13 WO PCT/EP2013/059814 patent/WO2013171159A1/en active Application Filing
- 2013-05-13 SG SG11201407536UA patent/SG11201407536UA/en unknown
- 2013-05-13 EA EA201492091A patent/EA201492091A1/ru unknown
- 2013-05-13 MX MX2014013851A patent/MX2014013851A/es unknown
- 2013-05-13 JP JP2015512013A patent/JP2015516455A/ja active Pending
- 2013-05-13 EP EP13722416.8A patent/EP2849739A1/en not_active Withdrawn
- 2013-05-13 US US14/398,875 patent/US20150111971A1/en not_active Abandoned
- 2013-05-13 CA CA 2872210 patent/CA2872210A1/en not_active Abandoned
- 2013-05-13 BR BR112014028280A patent/BR112014028280A2/pt not_active IP Right Cessation
- 2013-05-13 AU AU2013261918A patent/AU2013261918A1/en not_active Abandoned
- 2013-05-13 KR KR20147031487A patent/KR20150013162A/ko not_active Application Discontinuation
- 2013-05-14 AR ARP130101657 patent/AR091039A1/es unknown
-
2014
- 2014-10-21 ZA ZA2014/07655A patent/ZA201407655B/en unknown
- 2014-10-21 IL IL235241A patent/IL235241A0/en unknown
- 2014-11-11 PH PH12014502512A patent/PH12014502512A1/en unknown
- 2014-11-13 CL CL2014003081A patent/CL2014003081A1/es unknown
- 2014-11-13 CO CO14251765A patent/CO7131352A2/es unknown
-
2015
- 2015-04-08 HK HK15103459.1A patent/HK1202808A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014013851A (es) | 2015-02-12 |
| US20150111971A1 (en) | 2015-04-23 |
| CN104302281A (zh) | 2015-01-21 |
| EA201492091A1 (ru) | 2015-03-31 |
| AU2013261918A1 (en) | 2014-11-06 |
| CL2014003081A1 (es) | 2015-03-27 |
| AR091039A1 (es) | 2014-12-30 |
| ZA201407655B (en) | 2015-06-24 |
| JP2015516455A (ja) | 2015-06-11 |
| KR20150013162A (ko) | 2015-02-04 |
| WO2013171159A1 (en) | 2013-11-21 |
| CO7131352A2 (es) | 2014-12-01 |
| HK1202808A1 (en) | 2015-10-09 |
| IL235241A0 (en) | 2014-12-31 |
| CA2872210A1 (en) | 2013-11-21 |
| BR112014028280A2 (pt) | 2019-09-24 |
| EP2849739A1 (en) | 2015-03-25 |
| EP2664327A1 (en) | 2013-11-20 |
| TW201350107A (zh) | 2013-12-16 |
| PH12014502512A1 (en) | 2014-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201810423XA (en) | Pd-1 / pd-l1 inhibitors for cancer treatment | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201408094YA (en) | Neprilysin inhibitors | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
| SG11201806267QA (en) | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201808686VA (en) | Synthesis of indazoles | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201406787TA (en) | Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201406588YA (en) | A tow line controlling device and method of controlling same | |
| SG11201408685WA (en) | Antibacterial microelement chelates and the use thereof in animal feeds | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201908568XA (en) | Therapeutic compounds and methods | |
| SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction |